Verici DX
VRCI · AIM · Health Care · mcap £5.1m · 0.2p
- Revenue
- £2.6m
- Operating profit
- −£5.9m
- Net income
- −£5.9m
- Free cash flow
- −£6.6m
- Net cash
- £1.8m
- Market cap
- £8.9m
- EV / EBIT
- –
- FCF yield
- −74.4%
- Price / book
- 2.1×
- Revenue
- £1.3m −11%
- Operating profit
- −£3.0m prior −£2.4m
- Net income
- −£3.0m prior −£2.4m
- Cash from operations
- −£2.8m prior −£2.7m
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Half-year Results, published 30 Sep 26 · read the announcement ↗
Consolidated condensed statement of profit or loss and other comprehensive income · for the six months ended 30 June 2026
| Six months to 30 June 2026 US$’000 Unaudited | Six months to 30 June 2025 US$’000 Unaudited | Year to 31 December 2025 US$’000 Audited | |
|---|---|---|---|
| Revenue Cost of sales | (352) | 3,664 | (826) |
| _________ _________ _________ | |||
| 1,274 | 1,561 | 2,838 | |
| Administrative expenses | (4,824) | (4,229) | (9,020) |
| Depreciation and amortisation | (297) | (300) | (568) |
| Share-based payments | (161) | (132) | (222) |
| _________ _________ _________ | |||
| Loss from operations | (4,008) | (3,100) | (6,972) |
| Finance income | 1 | 19 | 67 |
| Finance expense | (23) | (9) | (17) |
| _________ _________ _________ | |||
| Loss before tax | (4,030) | (3,090) | (6,922) |
| Tax expense | 4 | - | (11) |
| _________ _________ _________ | |||
| Loss from continuing operations | (4,034) | (3,090) | (6,933) |
| Other comprehensive income | |||
| Exchange gains arising on translation of foreign operations | (32) | 175 | 64 |
| _________ _________ _________ | |||
| Loss and total comprehensive income attributable to the owners of the Company | (4,066) | (2,915) | (6,869) |
Consolidated statement of financial position · as at 30 June 2026
| 30 June 2026 US$’000 Unaudited | 30 June 2025 US$’000 Unaudited | 31 December 2025 US$’000 Audited | |
|---|---|---|---|
| Assets | |||
| Current assets | |||
| Trade and other receivables | 2,626 | 1,282 | 1,964 |
| Inventory | 45 | - | - |
| Cash and cash equivalents | 2,402 | 467 | 3,343 |
| _________ _________ _________ | |||
| 5,073 | 1,749 | 5,307 | |
| _________ _________ _________ | |||
| Non-current assets | |||
| Property, plant and equipment | 963 | 652 | 484 |
| Intangible assets | 2,116 | 2,144 | 2,149 |
| _________ _________ _________ | |||
| 3,079 | 2,796 | 2,633 | |
| _________ _________ _________ | |||
| Total assets | 8,152 | 4,545 | 7,940 |
| _________ _________ _________ | |||
| Liabilities | |||
| Current liabilities | |||
| Trade and other payables | (1,664) | (1,781) | (1,238) |
| Lease liabilities | (138) | (142) | (109) |
| Non-current liabilities Lease liabilities | (634) | (140) | (88) |
| _________ _________ _________ | |||
| NET ASSETS | 5,716 | 2,482 | 6,505 |
| _________ _________ _________ | |||
| Issued capital and reserves attributable to | |||
| owners of the parent | |||
| Share capital | 3,042 | 310 | 2,029 |
| Share premium reserve | 48,639 | 40,368 | 46,536 |
| Share-based payments reserve | 4,724 | 4,473 | 4,563 |
| Foreign exchange reserve | (642) | (499) | (610) |
| Retained earnings | (50,047) | (42,170) | (46,013) |
| _________ _________ _________ | |||
| TOTAL EQUITY | 5,716 | 2,482 | 6,505 |
Consolidated statement of cash flows · for the six months ended 30 June 2026
| Six months to 30 June 2026 US$’000 Unaudited | Six months to 30 June 2025 US$’000 Unaudited | Year to 31 December 2025 US$’000 Audited | |
|---|---|---|---|
| Cash flows from operating activities | |||
| Loss for the period | (4,034) | (3,090) | (6,933) |
| Adjustments for | |||
| Depreciation and amortisation | 297 | 300 | 568 |
| Finance income | (1) | (19) | (67) |
| Finance expense | 23 | 9 | 17 |
| Share-based payment expense | 161 | 132 | 222 |
| _________ _________ _________ | |||
| (3,554) | (2,668) | (6,193) | |
| (Increase) / decrease in trade and other receivables | (661) | (778) | (1,456) |
| (Increase) in inventory | (45) | - | - |
| Increase / (decrease) in trade and other payables | 489 | (74) | (616) |
| _________ _________ _________ | |||
| Net cash outflow from operating activities | (3,771) | (3,520) | (8,265) |
| _________ _________ _________ | |||
| Cash flows from investing activities | |||
| Purchases of property, plant and equipment | (14) | - | (2) |
| Purchase of intangibles | (85) | (62) | (187) |
| Interest received | 1 | 19 | 62 |
| _________ _________ _________ | |||
| Net cash used in investing activities | (98) | (43) | (127) |
| Cash flows from financing activities | |||
| Issue of ordinary shares | 3,235 | - | 8,596 |
| Expenses of share issue | (182) | - | (709) |
| Interest paid | (23) | (9) | (17) |
| Repayment of lease liabilities | (86) | (89) | (174) |
| _________ _________ _________ | |||
| Net cash from / (used in) financing activities | 2,944 | (98) | 7,696 |
| Net increase / (decrease) in cash and cash equivalents | (925) | (3,661) | (696) |
| Cash and cash equivalents at beginning of period | 3,343 | 4,061 | 4,061 |
| Exchange movement on cash and cash equivalents | (16) | 67 | (22) |
| _________ _________ _________ | |||
| Cash and cash equivalents at end of period | 2,402 | 467 | 3,343 |
Final Results, published 29 Jun 26 · read the announcement ↗
Consolidated statement of profit or loss and other comprehensive income · for the year ended 31 December 2025
| Year to 31 December 2025 US$'000 | Year to 31 December 2024 US$'000 | |
|---|---|---|
| Revenue | 3,664 | 3,339 |
| Cost of sales | (826) | - |
| _________ _________ | ||
| Gross profit | 2,838 | 3,339 |
| Administrative expenses | (9,020) | (8,709) |
| Depreciation and amortisation | (568) | (701) |
| Share-based payments | (222) | (35) |
| _________ _________ | ||
| Loss from operations | (6,972) | (6,106) |
| Finance income | 67 | 254 |
| Finance expense | (17) | (22) |
| _________ _________ | ||
| Loss before tax | (6,922) | (5,874) |
| Tax expense | (11) | - |
| _________ _________ | ||
| Loss from continuing operations | (6,933) | (5,874) |
| Other comprehensive income | ||
| Exchange gains arising on translation of foreign operations | 64 | 33 |
| _________ _________ | ||
| Total comprehensive loss | (6,869) | (5,841) |
| _________ _________ | ||
| Earnings per share attributable to the ordinary equity holders of the parent | ||
| Loss per share | ||
| Basic and diluted (US cents) | (0.9) | (2.5) |
Consolidated statement of financial position · as at 31 December 2025
| Year to 31 December 2025 US$'000 | Year to 31 December 2024 US$'000 | |
|---|---|---|
| Assets | ||
| Current assets | ||
| Trade and other receivables | 1,964 | 504 |
| Cash and cash equivalents | 3,343 | 4,061 |
| _________ _________ | ||
| 5,307 | 4,565 | |
| _________ _________ | ||
| Non-current assets | ||
| Property, plant and equipment | 484 | 858 |
| Intangible assets | 2,149 | 2,069 |
| _________ _________ | ||
| 2,633 | 2,927 | |
| _________ _________ | ||
| Total assets | 7,940 | 7,492 |
| _________ _________ | ||
| Liabilities | ||
| Current liabilities | ||
| Trade and other payables | (1,238) | (1,856) |
| Lease liabilities | (109) | (182) |
| Non-current liabilities - lease liabilities | (88) | (189) |
| _________ _________ | ||
| NET ASSETS | 6,505 | 5,265 |
| _________ _________ | ||
| Issued capital and reserves attributable to | ||
| owners of the parent | ||
| Share capital | 2,029 | 310 |
| Share premium reserve | 46,536 | 40,368 |
| Share-based payments reserve | 4,563 | 4,341 |
| Foreign exchange reserve | (610) | (674) |
| Retained earnings | (46,013) | (39,080) |
| _________ _________ | ||
| TOTAL EQUITY | 6,505 | 5,265 |
Consolidated statement of cash flows · for the year ended 31 December 2025
| Year to 31 December 2025 US$'000 | Year to 31 December 2024 US$'000 | |
|---|---|---|
| Cash flows from operating activities | ||
| Loss before tax | (6,933) | (5,874) |
| Adjustments for | ||
| Depreciation of property, plant and equipment | 376 | 522 |
| Amortisation of intangible fixed assets | 192 | 179 |
| Finance income | (67) | (254) |
| Finance expense | 17 | 22 |
| Share-based payment expense | 222 | 35 |
| _________ _________ | ||
| (6,193) | (5,370) | |
| (Increase) / decrease in trade and other receivables | (1,456) | 840 |
| (Decrease) in trade and other payables | (616) | (1,490) |
| Income taxes paid | - | - |
| _________ _________ | ||
| Net cash outflow from operating activities | (8,265) | (6,020) |
| _________ _________ | ||
| Cash flows from investing activities | ||
| Purchases of property, plant and equipment | (2) | (17) |
| Purchase of intangibles | (187) | (176) |
| Interest received | 62 | 254 |
| _________ _________ | ||
| Net cash (used in) / generated from investing activities | (127) | 61 |
| Cash flows from financing activities | ||
| Issue of ordinary shares | 8,596 | 8,196 |
| Share issue costs | (709) | (683) |
| Interest paid | (17) | (22) |
| Repayment of lease liabilities | (174) | (169) |
| _________ _________ | ||
| Net cash inflow from financing activities | 7,696 | 7,322 |
| Net (decrease) / increase in cash and cash equivalents | (696) | 1,363 |
| Cash and cash equivalents at beginning of year | 4,061 | 2,645 |
| Exchange (losses) / gains on cash and cash equivalents | (22) | 53 |
| _________ _________ | ||
| Cash and cash equivalents at end of year | 3,343 | 4,061 |
As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.
Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Revenue to operating profit | |||
| Revenue | 2.6 | 2.8 | 2.6 |
| Gross profit | 1.9 | 2.2 | 2.6 |
| Adjusted EBITDA | – | (4.7) | (4.2) |
| Operating profit | (5.9) | (5.3) | (4.8) |
| Depreciation (owned assets) | 0.3 | 0.3 | 0.4 |
| Amortisation | – | 0.1 | 0.1 |
| Share-based payments | (0.2) | (0.2) | (0.0) |
| Operating profit to net income | |||
| Finance costs | (0.0) | (0.0) | (0.0) |
| Profit before tax | (5.9) | (5.3) | (4.6) |
| Tax | – | (0.0) | 0.0 |
| Net income (owners) | (5.9) | (5.3) | (4.6) |
| Per share | |||
| EPS basic | – | (0.7p) | (2.0p) |
| EPS diluted | – | (0.7p) | (2.0p) |
| H1 26 | vs H1 25 | H2 25 | H1 25 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | 1.3 | −11% | 1.3 | 1.5 |
| Gross profit | 0.9 | −21% | 0.9 | 1.2 |
| Operating profit | (3.0) | n/m | (2.9) | (2.4) |
| Depreciation (owned assets) | 0.1 | −7% | 0.1 | 0.2 |
| Share-based payments | (0.1) | +18% | (0.1) | (0.1) |
| Operating profit to net income | ||||
| Finance costs | (0.0) | n/m | (0.0) | (0.0) |
| Profit before tax | (3.0) | n/m | (2.9) | (2.4) |
| Net income (owners) | (3.0) | n/m | (2.9) | (2.4) |
| Latest Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Non-current assets | |||
| Other intangibles | 1.6 | 1.6 | 1.6 |
| Property, plant & equipment | 0.7 | 0.4 | 0.7 |
| Non-current assets | 2.3 | 2.0 | – |
| Current assets | |||
| Inventories | 0.0 | – | – |
| Trade receivables | 2.0 | 1.5 | 0.4 |
| Cash | 1.8 | 2.5 | 3.2 |
| Current assets | 3.8 | 3.9 | – |
| Total assets | 6.2 | 5.9 | 6.0 |
| Current liabilities | |||
| Trade payables | 1.3 | 0.9 | 1.5 |
| Lease liabilities, current | 0.1 | 0.1 | 0.1 |
| Non-current liabilities | |||
| Lease liabilities, non-current | 0.5 | 0.1 | 0.2 |
| Equity | |||
| Total equity | 4.3 | 4.8 | 4.2 |
| H1 26 | H2 25 | H1 25 | H2 24 | |
|---|---|---|---|---|
| Non-current assets | ||||
| Other intangibles | 1.6 | 1.6 | 1.6 | 1.6 |
| Property, plant & equipment | 0.7 | 0.4 | 0.5 | 0.7 |
| Non-current assets | 2.3 | 2.0 | 2.0 | – |
| Current assets | ||||
| Inventories | 0.0 | – | – | – |
| Trade receivables | 2.0 | 1.5 | 0.9 | 0.4 |
| Cash | 1.8 | 2.5 | 0.3 | 3.2 |
| Current assets | 3.8 | 3.9 | 1.3 | – |
| Total assets | 6.2 | 5.9 | 3.3 | 6.0 |
| Current liabilities | ||||
| Trade payables | 1.3 | 0.9 | 1.3 | 1.5 |
| Lease liabilities, current | 0.1 | 0.1 | 0.1 | 0.1 |
| Non-current liabilities | ||||
| Lease liabilities, non-current | 0.5 | 0.1 | 0.1 | 0.2 |
| Equity | ||||
| Total equity | 4.3 | 4.8 | 1.8 | 4.2 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.